Ryeqo Unione Europea - italiano - EMA (European Medicines Agency)

ryeqo

gedeon richter plc. - relugolix, norethisterone acetate, estradiol hemihydrate - leiomioma - ormoni ipofisari e ipotalamici e analoghi - ryeqo is indicated in adult women of reproductive age for:- treatment of moderate to severe symptoms of uterine fibroids,- symptomatic treatment of endometriosis in women with a history of previous medical or surgical treatment for their endometriosis.

Ryeqo Compresse rivestite con film Svizzera - italiano - Swissmedic (Swiss Agency for Therapeutic Products)

ryeqo compresse rivestite con film

gedeon richter (schweiz) ag - relugolixum, estradiolum, norethisteroni acetas - compresse rivestite con film - relugolixum 40 mg, estradiolum 1 mg ut estradiolum hemihydricum, norethisteroni acetas 0.5 mg, mannitolum, carboxymethylamylum natricum a, hydroxypropylcellulosum, lactosum monohydricum 78.4 mg, magnesii stearas, Überzug: hypromellosum, e 171, lactosum monohydricum 1.77 mg, triacetinum, e 172 (flavum), pro compresso obducto corresp. natrium max. 0.581 mg. - therapie einer myom-assoziierten hypermenorrhoe bei erwachsenen frauen vor eintritt der menopause - synthetika